American Oncology Network Partners with InfuSystem to Provide Patients Ambulatory Infusion Pumps

/in /by

Enabling continuity of care for cancer patients from clinic to home

Fort Myers, Fla., Feb. 28, 2022 – American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings, announced today it has entered into an agreement with InfuSystem Holdings, Inc. (NYSE American: INFU) (InfuSystem), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, to provide ambulatory infusion pumps and services, effective January 1, 2022. As part of the agreement, InfuSystem will provide its ambulatory infusion pump service, which includes electronic infusion pumps for continuous chemotherapy treatment, a 24/7 clinical hotline, biomedical services, accompanying supplies and revenue cycle management.

Richard DiIorio, Chief Executive Officer of InfuSystem, said, “We are pleased to partner with AON to provide ambulatory infusion pumps and services across their network of oncology facilities in the U.S. This agreement will be a third-party payer model and serviced from our existing fleet of more than 100,000 infusion pumps to effectively manage the utilization of our fleet and our turnkey services. We believe this agreement further validates our value proposition for our customers to cost effectively provide infusion pumps and manage their fleets with best-in-class service in safely facilitating clinic-to-home care. We value this new partnership with AON and look forward to a long and successful relationship to improve patient wellness.”

Todd Schonherz, Chief Executive Officer of AON, said, “We are excited to be working with InfuSystem as they have a long history of providing industry leading customer service and patient support. Their commitment and skill set from providing infusion pumps to managing the revenue cycle will deliver significant efficiencies for AON. This allows us to focus on our expertise in delivering the best treatments to improve patient care and outcomes.”

###

About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services (“ITS”), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services (“DME Services”), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com 

American Oncology Network (AON) and VieCure Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care

/in /by

Collaboration offers clinicians access to a state-of-the-art, cloud based oncology decision support platform that fully integrates the latest codified clinical content and generates patient specific treatment plans at point of care. AON and VieCure have also committed to jointly advancing a multi-year technology development roadmap to ensure the latest clinical tools and content needed are available to participating clinicians and their patients

Denver, CO and Fort Myers, FL, February 23, 2022 – American Oncology Network, LLC (AON) , a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings, announced today a strategic collaboration with VieCure, a national leader in the deployment of Artificial Intelligence (AI), codified clinical content and point-of-care clinical decision support in oncology. The collaboration is designed to facilitate the delivery of precision oncology and personalized care and treatment for patients across the ever-expanding AON network.

Foundational to the future of oncology treatment is the execution of a vision for personalized medicine. Realizing this vision requires access to patients, oncologists and robust molecular information and patient outcomes data. This strategic collaboration will serve as a key vehicle to do just that. AON oncologists and staff will improve clinical decision-making at the individual patient level, while standardizing care plans and associated care delivery across the patient population to better outcomes. Longitudinal information which tracks the same type of information on the same patient at multiple times will be generated in real time as patients move throughout their complex cancer care journey. This information will be used to evaluate treatment approaches, create new value-based care funding options, improve overall treatment outcomes and provide insights into next generation prevention, screening, diagnostic and therapeutic opportunities. Given the value of the data and associated insights, AON and VieCure will work jointly with industry on transformational initiatives.

The parties have strategically aligned to accelerate the adoption of three critically important paradigm shifts that are currently underway in oncology, including: (1) the compliant use of next generation tumor sequencing, targeted therapy, immunotherapy and emerging therapies such as radio-ligands; (2) the transition to value-based care, and (3) increasing patient participation in the management of their care given more and more patients are living longer with their disease and being treated at home. While these transformational changes are improving overall survival and quality of life for patients, they are also driving the need for change at the point of care given oncologists are having to evaluate an ever growing amount of patient data and clinical evidence.

“Clinicians want to do what’s best for their patients, for their staff and for practices,” said Dr. Stephen “Fred” Divers, Chairman of the AON Advisory Board and a practicing Medical Oncologist. “They want to make the right decisions at the right time, but they’re often overwhelmed by data which is poorly accessible and manageable, leading to clinical workflow burdens which get in the way of achieving the best outcomes for their patients. They need a technology solution that helps simplify cancer’s complexities and empowers them to do their best. At AON, we partner with physicians and their practices to help them navigate the complex oncologic landscape, improve quality of care and elevate oncology in community settings. VieCure aligns perfectly with that mission.”

AON leadership recognized the need for 21st century clinical decision making tools and turned to VieCure to be their partner. The two entities will work together to codify AON’s unique clinical content including but not limited to therapeutic and drug contracts, commercial payer rules and clinical trials.

“We understand that knowledge is the secret to beating cancer,” said Dr. Fred Ashbury, Chief Scientific Officer at VieCure. “That’s why we’re embracing the power of clinical inferencing to do what the human brain cannot, which is to enable clinicians to easily sift through the overwhelming amount of information to find the right answers for every patient, every time. At VieCure we’re about creating simplexity in cancer care, which means we use AI technology to cut through the dense fog of information that holds clinicians back; we help to superpower them to do their best work. By codifying the latest in clinical evidence and financial rules, we can envelop our clinicians with a halo of knowledge in real time which can be easily and quickly interpreted and actioned right at the point of care.”

The multi-year strategic collaboration will not only serve to meet the clinical needs of the AON community today but will ensure the VieCure™ platform evolves over time. Together the parties have committed to:

  • Joint research and development, creating and deploying new features and technology innovations as the oncology landscape changes.
  • Advancing access to, and administration of, the latest codified content including national and international evidence, therapy (eg. drug/bio-similar) agreements, and phase I, II, and III clinical trials.
  • Centralization of precision oncology infrastructure including one-click order entry for next generation tumor sequencing and the return of relevant discrete data to facilitate real-time clinical inferencing of results to help guide treatment selection and management decisions. 
  • Facilitation of joint/new partnerships with industry collaborators – clinical research, radiation therapy, radioligand, pharma and molecular diagnostic partners.
  • Facilitating clinical paradigm shifts and appropriate adoption of radioligand therapy, proteomics, biology guided radiotherapy, digital transformation at the patient/family level, and more.
  • Advancing value-based care in a personalized cancer care and precision oncology environment.

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

About VieCure
VieCure has developed a proprietary artificial intelligence informatics software platform in conjunction with a clinical inference engine and point of care decision support system in oncology. The VieCure™ platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. VieCure was launched in 2015 and has contracted with leading community oncology cancer centers like the Center for Cancer and Blood Disorders (Fort Worth, Texas), Alabama Cancer Care (Tuscaloosa, Alabama), Clermont Oncology (Clermont, Florida), and several others including the American Oncology Network. The VieCure contracted cancer center network now includes more than 100 locations in the United States, the Bahamas and Antigua. Active implementation of the VieCure platform is occurring in network locations across the United States and the Caribbean. For more information, please visit viecure.com and connect with VieCure on LinkedIn, Facebook and YouTube.

American Oncology Network Joins Forces with Rapides Cancer Center to Expand Cancer Services

/in /by

Rapides Regional investing $10 million to enhance cancer program

Alexandria, La., Jan. 20, 2022 – Rapides Cancer Center and American Oncology Network are joining forces to provide advanced, comprehensive and convenient care for patients in Central Louisiana.

A Division of American Oncology Partners, Hematology Oncology Clinic (HOC) at Rapides will begin seeing patients in January in a new clinic inside Rapides Cancer Center located on the campus of Rapides Regional Medical Center. Rapides Cancer Center is a Division of Rapides Regional Medical Center and has been accredited by the Commission on Cancer since 1972.

HOC at Rapides will be part of the American Oncology Network, a growing medical oncology provider with a focus on supporting the long-term viability of cancer treatment in communities across the country. With AON support and ancillary services, HOC at Rapides will provide improved access to advanced oncology care in Central Louisiana. AON includes an expanding team of 105 physicians providing care at numerous locations in 16 states.

The HOC at Rapides team will include Medical Oncologists Michael Castine III, M.D., Pavani Ellipeddi, M.D., Christopher McCanless, M.D. and Gerald Miletello, M.D. and Nurse Practitioner Kasey Gill. This will be HOC’s third location in Louisiana, joining clinics in Baton Rouge and Zachary.

“This partnership represents a new day in cancer care for our community,” said Jason Cobb, Chief Executive Officer of Rapides Regional Medical Center. “Our community will be able to receive world-class care based on a patient-centered care model without having to leave home. With the recent Rapides Cancer Center renovations and upgrades in technology, we are proud to offer Central Louisiana cancer care on a higher level than ever before.”

Rapides Regional Medical Center is investing $10 million to enhance its cancer program. The upgrades include the first TrueBeam linear accelerator in Central Louisiana to provide the latest technology in radiation oncology. Coming in early 2022, RRMC will open the Rapides Breast and Diagnostic Center and install the first 64-slice PET CT Scanner to be located in a cancer center in Louisiana, allowing oncologists to pinpoint the precise tissue location of tumors.

The 7,700 square-foot HOC at Rapides practice is expected to open in mid-January. The state-of-the-art facility will include six exam rooms and 14 chemotherapy chairs, and will offer infusion therapy, including chemotherapy and immunotherapy, an in-house laboratory performing all routine blood work on-site and an in-house specialty pharmacy. Patients will have access to clinical trials, care management support, including nutrition guidance, Oncology Care Model participation and financial counseling.

“The entire Hematology Oncology Clinic at Rapides team is committed to enhancing the patient experience in order to have a greater impact on those who need care,” said Dr. Castine. “We hope to create the type of experience that patients expect and deserve, placing them at the very pinnacle of cancer care today.”

HOC at Rapides is committed to providing the community with the highest quality care that is based on research, evidence-based medicine and focused on the whole person. Cancer patients will now have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, patient support and amenities under one roof, giving them unparalleled access to comprehensive, integrated cancer care, close to home.

“A key differentiator of AON is flexibility for our partner practices,” said AON Chief Executive Officer Todd Schonherz. “Hematology Oncology Clinic at Rapides is able to leverage AON support for pharmaceutical purchasing strategies, revenue cycle, payer negotiations, human resources and technology to form a strong hospital partnership that will enable practice growth while bringing comprehensive cancer care services to Alexandria residents.”

“With these entities joining forces, it will advance the mission of both organizations,” said Cobb. “Together, we are transforming the future of cancer care in our region and it is our cancer patients who will reap the benefit of this partnership.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

About Hematology/Oncology Clinic: (HOCBR.com)
Specialists in the diagnosis and treatment of blood disorders and cancer, Hematology Oncology Clinic (HOC) serves patients from offices in Baton Rouge, Zachary and Alexandria. HOC is the practice of Dr. Gerald Miletello, Dr. Christopher McCanless, Dr. Michael Castine, III and Dr. Pavani Ellipeddi. The practice’s highly trained and experienced clinical staff consists of Nurse Practitioners, Oncology Certified Registered Nurses and Licensed Practical Nurses.

HOC’s exceptional quality care includes access to innovative clinical trials, an in-house specialty pharmacy, timely labs and pathology reports, and on-site infusion therapy. The practice also offers comprehensive supportive care such as access to Care Management, nutrition counseling, and much more.

About Rapides Regional Medical Center: (rapidesregional.com)
Rapides Regional Medical Center is a 380-bed acute care hospital located in Alexandria, La., providing healthcare on a higher level for families in approximately 16 central Louisiana parishes. Our mission is to provide high quality, efficient and compassionate health care services for our patients and community through the efforts of our employees, physicians and volunteers.

Rapides Regional Medical Center has provided state-of-the-art, comprehensive medical services to our community for 118 years. Our campus is home to Rapides Women’s and Children’s Hospital, Rapides Cancer Center, Rapides Outpatient Center, Rapides Regional Trauma Center, 51-bed emergency department, NICU, PICU and ICU. Read about these services and more at rapidesregional.com.

For More Information, Contact:
Rapides Regional Medical Center
Charla Ducote, Vice President of  Marketing, Public Relations & Business Development
charla.ducote@hcahealthcare.com

American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Appoints New Executive Board Member

/in /by

Fort Myers, Fla., Jan. 19, 2022 – The American Oncology Network, LLC (AON), whose mission is to support the long-term viability of community oncology, is pleased to announce that Medical Oncologist Shalin R. Shah, DO has been named to its Executive Board, providing strategic guidance to its growing network of over 100 physicians across 16 states. He joins current Executive Board members: Stephen Orman, MD, Douglas Heldreth, MD, Vipul Patel, MD and Daniel Spitz, MD. Dr. Craig Reynolds who joined the Board in 2020, has stepped down from the position.

After graduating from the University of Miami, Dr. Shah completed his residency at the University of Florida in Jacksonville, Fla., followed by a fellowship in oncology. Dr. Shah is a medical oncologist and hematologist with Florida Cancer Specialists & Research Institute and practices in Tampa, Fla. He focuses on the treatment of adult solid tumor malignancies, both benign and malignant hematology, and has an interest in clinical trial participation as well. He has served multiple terms on the Executive Board of the largest privately held oncology group in the United States and is a former member of their Finance Committee. He is also a board member of the Florida Society of Clinical Oncology (FLASCO) and was the previous Vice President of the Clinical Practice Committee for FLASCO. Dr. Shah actively serves on several other boards in healthcare, technology, and education.

AON Chief Executive Officer Todd Schonherz said “With more than three decades of expertise in all areas of oncology practice management, AON empowers physicians to make cancer care better and provide the best possible patient experience. The addition of Dr. Shah to our Board strengthens our ability to ensure the long-term success of community oncology.”

AON Board Member & Chairman Dr. Stephen Orman added “We’re thankful for Dr. Reynolds’ commitment and leadership and so pleased to welcome such an experienced and highly respected physician as an addition to the Board. Our Board members do an excellent job helping our partners successfully navigate today’s rapidly changing healthcare landscape while serving the needs of their patients.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

Low Country Cancer Care Expands Further in Georgia & Opens New Statesboro Clinic

/in /by

Statesboro, Ga., Jan. 5, 2022 – Low Country Cancer Care (LCCC), is pleased to announce the opening of their new cancer center in Statesboro, Ga., located at 1601 Fair Road, Suite 900. This new clinic is the fifth LCCC location, making it easier for patients to have access to the highest quality cancer care close to where they live.

Other locations are in Savannah, Hinesville and Pooler, Ga., and Bluffton, S.C. The team consists of seven providers including four medical oncologists, one physician assistant and two nurse practitioners. LCCC offers a comprehensive range of treatments for patients diagnosed with cancer and blood disorders.

In 2020, LCCC joined the American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings. The LCCC and AON partnership helps provide the best cancer care with additional services including in-house pathology and specialty pharmacy, access to a care management team and financial assistance programs to help navigate insurance coverage.

AON Chief Executive Officer Todd Schonherz said, “Low Country Cancer Care and AON believe every patient deserves access to affordable yet high-quality cancer care in the communities where they live.”

LCCC is committed to providing the community with innovative cancer care that is based on research, evidence-based medicine and focused on the whole person. Cancer patients will now have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship and patient support, giving them unparalleled access to comprehensive, integrated cancer care, close to home.

“Dr. Negrea and I are pleased to provide medical oncology and hematology services in Statesboro, so we can serve patients close to their home. Our decision to expand to better serve patients in this area continues the vision we share with AON of positively impacting patients’ lives,” said Low Country Cancer Care Medical Oncologist Dr. Rohit Bishnoi.

AON President & Chief Development Officer Brad Prechtl, MBA stated, “This expansion makes it the fourth clinic we have opened in Georgia, showing our commitment to offering patients access to the latest advancements and cancer treatments right where they live.”

###

About Low Country Cancer Care: (LCCCSav.com)
Low Country Cancer Care has five locations, including one office in Savannah and four satellite offices in Hinesville, Statesboro and Pooler, Georgia and Bluffton, South Carolina. The team includes four medical oncologists, one physician assistant and two nurse practitioners who provide a comprehensive range of treatment for patients diagnosed with cancer and blood disorders.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network and Cancer & Blood Specialists of Arizona Open New Flagstaff Office

/in /by

Fort Myers, Fla., Jan. 5, 2022 – American Oncology Network, LLC (AON) and its partner, Cancer & Blood Specialists of Arizona (CBSA), are pleased to announce the opening of their new cancer center location in Flagstaff, Ariz., located at 77 W. Forest Avenue, Suite 301.  This new clinic is the fourth CBSA location, making it easier for patients to have access to the highest quality cancer care close to where they live. Medical oncologist Peter Mathern, MD will be practicing at this new site.

Other locations are in central and north Phoenix and Gilbert.  The team consists of eleven providers including five medical oncologists, two gynecologic oncologists and four nurse practitioners.  CBSA offers a comprehensive range of treatments for patients diagnosed with cancer and blood disorders.

In February 2021, CBSA joined AON, a high-growth national medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings.

Dr. Peter Mathern of the CBSA Flagstaff office said, “This clinic will offer our patients the same great care they are accustomed to receiving with advances in clinical research and therapies, 24/7 pharmacy assistance and in-house pathology, laboratory and pharmacy services.”

“The opening of this Flagstaff clinic is aligned with our mission of providing the best cancer care that is affordable and close to where our patients live,” said Brad Prechtl, MBA, AON President & Chief Development Officer.

AON Chief Executive Officer Todd Schonherz added, “Dr. Mathern and his team have been serving patients in the Flagstaff area for over 12 years. By joining Cancer & Blood Specialists of Arizona and the AON network, he’ll be part of a larger collaborative team. This type of team approach always leads to higher-quality patient care.”

###

About Cancer & Blood Specialists of Arizona: CancerBloodSpecialistsAZ.com

Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix and Flagstaff, Arizona, and surrounding areas. Our physicians have deep roots in the communities we serve delivering the highest quality cancer treatment that is based on cutting-edge research.

About American Oncology Network, LLC: AONcology.com

American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network currently represents 104 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt
Vice President of Marketing
Caroline.Hewitt@AONcology.com

Partner Oncology Announces Rebranding, Changes Name to Panacea Oncology

/in /by

Puyallup, Wash., Jan. 3, 2022 – Partner Oncology, serving Puyallup and the Lakewood areas in oncology and hematology, recently rebranded the practice name to Panacea Oncology (Panacea). Panacea provides personalized and compassionate care, offering cancer patients in Pierce County the most advanced treatments of the highest quality.

The name was changed to show the wider scope of value and services offered. Panacea means a solution or remedy for all diseases which embodies Panacea’s mission of innovative care based on research and evidence-based treatment.

Panacea Medical Oncologist Dr. Joseph Ye said, “The available resources we have in this constantly changing world of complex diseases of oncology and blood disorders allows us to better serve our patients. We felt it was necessary to rebrand our practice to better represent the exceptional cancer care we provide right here in the communities where our patients live.”

In addition to the name change Panacea also introduced a new logo design which features all the colors from the cancer awareness ribbons. These colors represent all the indications of cancer.

AON Chief Executive Officer Todd Schonherz said, “The new Panacea identity better aligns with the clinical services offered while making a more memorable impression.”

Panacea Oncology Medical Oncologists Drs. Joseph Ye, Xinda David Wang and Weigang Tong are part of the American Oncology Network, LLC (AON)—a leading physician network helping community oncologists have greater access to more resources so patients get top-level cancer care within their communities.

###

About Panacea Oncology: (PanaceaOncology.com)
Panacea Oncology (Panacea) offers convenient access to quality cancer and hematology care for patients in Puyallup and Lakewood, Washington. A community-based practice, Panacea provides medical oncology/hematology services and infusion therapy including immunotherapy for treating cancer and other diseases.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

Zangmeister Cancer Center Expands Cancer Care Services & Opens in Grove City, Ohio

/in /by

Grove City, Ohio, Jan. 3, 2022 – Zangmeister Cancer Center (Zangmeister), an American Oncology Network, LLC (AON) partner practice, is pleased to announce the opening of its new cancer center in Grove City, Ohio at 5500 N. Meadows Drive, Suite 230.

The physicians of Zangmeister have been serving patients in the Columbus area with high-quality cancer care for over 30 years and are excited to expand to Grove City to provide patients within the community the same great care. At the new clinic, patients will have access to in-house lab and pathology, infusion therapy and financial counseling. Zangmeister Medical Oncologists providing care to patients in Grove City are Dr. Sam Mikhail and Dr. Jorge Rios.

“We serve the local community as an independent oncology practice focused on providing the best oncology and hematology care while also responsibly controlling cancer costs for patients,” said Zangmeister Medical Oncologist Dr. Sam Mikhail. “This combination ensures the best possible outcomes while reducing financial burdens for patients.”

“As a long-term community oncology practice, the Zangmeister model of care is to provide the best possible yet affordable care close to where their patients live. The opening of this new clinic will bring Grove City patients access to the latest advancements in diagnosing and treating cancer right in the community where they live,” said AON Chief Executive Officer Todd Schonherz.

AON President & Chief Development Officer Brad Prechtl, MBA added, “Our Grove City patients will have access to a diverse range of support services including 24/7 pharmacy assistance, behavioral therapy, nutrition and financial counseling—giving them unparalleled access to comprehensive, integrated cancer care, close to home.”

Zangmeister offers comprehensive medical oncology and hematology treatment close to home. Zangmeister physicians collaborate with their colleagues in radiation therapy, surgery, genetics, pathology and clinical research to ensure each patient has a comprehensive, multidisciplinary plan of care. Support from in-house pharmacists, social workers, nurse navigators, dietitians and financial counselors minimize the impact of cancer on daily life.

###

About Zangmeister Cancer Center: (ZangCenter.com)
The Zangmeister Cancer Center offers comprehensive medical oncology, gynecologic oncology and hematology treatment close to home. Designed for easy access and patient comfort, the center offers many services that patients need as part of their cancer care, including diagnostic imaging, chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services and access to cancer clinical trials.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Physicians Research is Well Represented at the ASH Annual Meeting & Exposition

/in /by

Fort Myers, Fla., Dec. 16, 2021 – American Oncology Network, LLC (AON) is pleased to announce that eight research studies co-authored by AON physicians were presented at the American Society of Hematology (ASH) Annual Meeting & Exposition, held December 11-14, 2021.

Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 are accepted for oral and poster presentations through an extensive peer review process.

The following AON physician investigators presented their research results during poster discussions and/or presentations.

  • Dr. Ruemu E. Birhiray of Hematology Oncology of Indiana, who served as co-author of a study titled an Extended Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy in the Community-Based United States (US) MM-6 Study: Updated Efficacy and Safety, and Reasons for Premature Discontinuation (Abstract # 2726)
  • Dr. Ralph V. Boccia of The Center for Cancer and Blood Disorders, who served as co-author of several studies titled a Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma (Abstract # 2742) and the Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (Abstract # 2727)
  • Dr. Arvind Chaudhry of Summit Cancer Centers, who presented and served as co-author of several studies titled the Efficacy and Safety of the BTK Inhibitor MK-1026 in Patients with Hematologic Malignancies: Phase 2 Study (Abstract # 3737) and a Phase 2 Study of Zanubrutinib in BTK Inhibitor – Intolerant Patients with Relapsed / Refractory B-Cell Malignancies (Abstract # 1410)
  • Dr. Christopher Chay of Messino Cancer Centers, who served as co-author of a study titled BRUIN MCL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress) (Abstract # 2422)
  • Dr. Victor M. Priego of The Center for Cancer and Blood Disorders, who served as co-author of several studies titled A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies (Abstract # 1355) and Rusfertide (PTG-300), a Hepcidin Mimetic, Maintains Liver Iron Concentration in the Absence of Phlebotomies in Patients with Hereditary Hemochromatosis (Abstract # 943)

AON CEO Todd Schonherz said, “The physicians within our network are dedicated to bringing innovative treatment options to patients, close to home. To have eight AON physicians’ research studies being shared at this prestigious program confirms that our physicians are not only uniting in collaboration, they’re at the forefront of new discoveries and findings that will expand and improve blood disease treatment options for every patient.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network & Partner Oncology
Welcome Weigang Tong, MD, PhD

/in /by

Puyallup, Wash., Dec. 1, 2021 – Drs. Joseph Ye and Xinda David Wang of Partner Oncology (PO) are pleased to announce that Medical Oncologist Weigang Tong, MD, PhD has joined the community oncology practice with locations in Puyallup and Lakewood, Washington. An American Oncology Network, LLC (AON) practice, Partner Oncology provides comprehensive treatment for patients diagnosed with cancer and blood disorders.

Dr. Tong earned his medical degree from West China University of Medical Science and then pursued a PhD in biomedical sciences from Creighton University School of Medicine in Omaha, Neb. He completed two research fellowships in stem cell and leukemia and a fellowship in hematology and oncology from the University of Washington.

“Dr. Tong is joining our community oncology practice because he wants the freedom to care for his patients in a more personalized setting,” said Partner Oncology Medical Oncologist Dr. Joseph Ye. “His approach to patient care is to engage with patients, families and their caregivers to help improve their overall quality of life.”

Dr. Tong treats patients with a broad spectrum of hematology and oncology conditions and has a special interest in malignant hematology, such as leukemia, lymphoma and multiple myeloma. He also has a special interest in gastrointestinal malignancy and breast cancer treatments.

“We are pleased to welcome Dr. Tong to Partner Oncology and AON as he shares our vision of providing high quality cancer care close to where our patients live,” said AON President & Chief Development Officer Brad Prechtl, MBA.

AON Chief Executive Officer Todd Schonherz added, “Dr. Tong forms a special bond with his patients, providing guidance and reassurance while offering them the best possible treatment that is available.”

###

About Partner Oncology: (PartnerOncology.com)
Partner Oncology (PO) offers convenient access to quality cancer and hematology care for patients in Puyallup, Washington. A community-based practice, PO provides medical oncology/hematology services and infusion therapy including immunotherapy for treating cancer and other diseases.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com